Multiple myeloma advances for the future suggested by phase I clinical research
20 Dec 2012
Multiple myeloma advances for the future suggested by phase I clinical research
Advances in myeloid disease from ASH 2012 from the Sarah Cannon Research Institute
Investigation of Ki67 biomarker
A need for clarity in clinical trial end points
Expanding international collaboration at IFOM
Perception of inequalities in care and cancer registries
Development of clinical trials and biobanks
Participation in clinical trials
A multi-discipline approach to personalised medicine
Challenges to the development of personalised medicine
Progress of personalised oncology treatment
Role of ECCO in the development of personalised oncology treatment